Foundation Medicine (FMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,404 | 63,617 | 117,763 | 72,080 | 124,293 |
| Marketable Securities | 0 | 79,402 | 89,607 | N/A | N/A |
| Receivables | 30,126 | 10,213 | 7,765 | 9,894 | 6,262 |
| Inventories | 13,171 | 10,438 | 7,992 | 4,809 | 1,763 |
| TOTAL | $123,819 | $168,921 | $229,644 | $89,648 | $133,310 |
| Non-Current Assets | |||||
| PPE Net | 41,119 | 41,486 | 41,333 | 21,015 | 22,104 |
| Investments And Advances | 0 | 0 | 24,939 | 0 | 0 |
| Other Non-Current Assets | 4,065 | 3,628 | 2,073 | 1,275 | 1,854 |
| TOTAL | $45,184 | $45,114 | $68,345 | $22,290 | $23,958 |
| Total Assets | $169,003 | $214,035 | $297,989 | $111,938 | $157,268 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,926 | 11,898 | 10,469 | 7,263 | 7,007 |
| Accrued Expenses | 36,745 | 20,578 | 12,822 | 7,414 | 5,168 |
| Other current liabilities | 1,818 | 2,324 | 2,146 | 1,429 | 1,167 |
| TOTAL | $66,443 | $40,651 | $29,896 | $16,446 | $15,759 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60,000 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 5,954 | 5,851 | 4,459 | 340 | 918 |
| Other Non-Current Liabilities | 10,892 | 8,538 | 10,404 | 9,323 | 9,798 |
| TOTAL | $70,892 | $8,538 | $10,404 | $9,323 | $9,798 |
| Total Liabilities | $137,335 | $49,189 | $40,300 | $25,769 | $25,557 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,882 | 35,419 | 34,541 | 29,132 | 27,664 |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -506,349 | -344,808 | -231,616 | -141,985 | -89,763 |
| Other shareholders' equity | 109 | -14 | -178 | 0 | 0 |
| TOTAL | $31,668 | $164,846 | $257,689 | $86,169 | $131,711 |
| Total Liabilities And Equity | $169,003 | $214,035 | $297,989 | $111,938 | $157,268 |